Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Clinical trial NCT00438659 · COMPLETED

Trial details

NCT number: NCT00438659
Sponsor: North Central Cancer Treatment Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Dermatologic Complications Radiation Toxicity Skin Reactions Secondary to Radiation Therapy

Start date: 2007-08-01
Primary completion: 2010-01-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.